<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Sample Clinical Trial Protocol – Moringa Observational Study</title>
    <style>
        body {
            margin: 0;
            font-family: Arial, sans-serif;
            background: #f4f4f4;
            color: #333;
            line-height: 1.6;
        }
        header {
            background: linear-gradient(90deg, #2C3E50, #3498DB);
            color: white;
            padding: 1.5rem;
            text-align: center;
        }
        section {
            max-width: 900px;
            margin: 2rem auto;
            padding: 1.5rem;
            background: #fff;
            border-radius: 8px;
            box-shadow: 0 0 10px rgba(0,0,0,0.1);
        }
        h2 {
            color: #4a148c;
            margin-top: 0;
        }
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 1rem 0;
        }
        th, td {
            border: 1px solid #ddd;
            padding: 0.5rem;
            text-align: left;
        }
        th {
            background: #e1bee7;
        }
        .checklist span {
            margin-right: 0.5rem;
        }
        .done {
            color: green;
        }
    </style>
</head>
<body>
    <header>
        <h1>Sample Clinical Trial Protocol</h1>
        <h2>A Prospective Observational Study Evaluating the Wellness Effects of <em>Moringa oleifera</em> Supplementation on Post‑Chemotherapy Fatigue in Breast‑Cancer Survivors</h2>
        <h3>Moringa Observational Study – Master Implementation Blueprint</h3>
        <p><strong>Version 1.1</strong></p>
        <p>Compiled by <strong>Tengu Muna</strong><br><em>Global Clinical Trial Strategist • AI Innovator • Coach</em></p>
        <p>This is a <strong>simulated clinical research protocol</strong> designed for prototyping purposes only. It showcases how an observational study could be presented, structured, and implemented by a study strategist in real-world environments.</p>
        <p><small>© 2025 Tengu Muna. This content is confidential and intended solely for evaluative and demonstration purposes. Unauthorized reproduction or distribution is prohibited.</small></p>
    </header>

    <section>
        <h2>1. Protocol Snapshot</h2>
        <table>
            <tr><th>Parameter</th><th>Detail</th></tr>
            <tr><td>Design</td><td>Prospective, single‑arm, remote ePRO study (FACIT‑F, PROMIS‑29, PSQI‑S)</td></tr>
            <tr><td>Sites</td><td>3–5 diverse U.S. sites (academic + community + FQHC)</td></tr>
            <tr><td>Participants</td><td>N=60 female breast‑cancer survivors, 6–12 mo post‑chemotherapy</td></tr>
            <tr><td>Dose / Duration</td><td>2 × 500 mg Moringa capsules daily for 12 weeks</td></tr>
            <tr><td>Primary Endpoint</td><td>FACIT‑Fatigue change (Baseline → Week 12)</td></tr>
            <tr><td>Enrollment Window</td><td>Weeks 8–20 (~12 wks)</td></tr>
            <tr><td>DB Lock → Final Report</td><td>Weeks 35–41</td></tr>
        </table>
    </section>

    <section>
        <h2>2. Project Management Overview</h2>
        <ul>
            <li><strong>Codex Dashboard:</strong> Live milestone tracker, budget variance, query aging, diversity KPI pie.</li>
            <li><strong>Budget:</strong> USD $181 k incl. 10 % contingency.</li>
            <li><strong>Critical Path:</strong> IRB approval → Site contract → Dynamic REDCap build → FPI.</li>
        </ul>
    </section>

    <section>
        <h2>3. Data Strategy</h2>
        <ul>
            <li><strong>Platform:</strong> REDCap Cloud; 1 dynamic visit form.</li>
            <li><strong>Source:</strong> ePRO = source; site eCRFs limited to AE verification & bottle counts.</li>
            <li><strong>QC:</strong> Auto range & missing edits; weekly query cycle; lock after SAE recon.</li>
            <li><strong>Archive:</strong> REDCap “Offline ZIP” + SHA‑256 hash stored in TMF.</li>
        </ul>
    </section>

    <section>
        <h2>4. Monitoring Framework</h2>
        <table>
            <tr><th>Visit</th><th>Mode</th><th>When</th><th>Focus</th></tr>
            <tr><td>SIV</td><td>Remote</td><td>Pre‑enroll</td><td>Training, ePRO demo, IP SOP</td></tr>
            <tr><td>Bi‑Weekly Remote</td><td>Dashboard</td><td>Wk 9–32</td><td>ePRO % complete, AE/deviations</td></tr>
            <tr><td>Interim On‑Site</td><td>Physical</td><td>Wk 14 (±1)</td><td>10 % SDV, consent check, IP log</td></tr>
            <tr><td>Close‑Out</td><td>Remote</td><td>Post‑LPLV</td><td>Reconciliation, archive hand‑off</td></tr>
        </table>
        <p>KPIs: ≥ 90 % ePRO completion • Query aging &lt; 7 days • CAPA closure &lt; 30 days.</p>
    </section>

    <section>
        <h2>5. IP Supply & Accountability</h2>
        <ul>
            <li>GMP lot COA, HDPE 120‑caps bottles, ambient FedEx 2‑Day with TempTale.</li>
            <li>Site storage 15‑25 °C; daily min/max; bottle IDs logged in REDCap.</li>
            <li>Returns reconciled at Week 12; site destroys or ships to depot.</li>
        </ul>
    </section>

    <section>
        <h2>6. Safety Management Plan</h2>
        <table>
            <tr><th>Component</th><th>Detail</th></tr>
            <tr><td>AE Capture</td><td>ePRO free‑text → site confirmation</td></tr>
            <tr><td>Coding</td><td>MedDRA v26 PT/SOC</td></tr>
            <tr><td>SAE Definition</td><td>Any event requiring hospitalization, life‑threatening, death, or judged supplement‑related</td></tr>
            <tr><td>Reporting Timelines</td><td>SAE initial ≤ 24 h; follow‑up ≤ 5 days</td></tr>
            <tr><td>Medical Review</td><td>SAE narrative signed by Medical Lead (PI Eq.)</td></tr>
            <tr><td>Signal Monitoring</td><td>Monthly CRO + Medical Lead review; threshold ≥ 5 related AEs triggers safety CAPA</td></tr>
        </table>
    </section>

    <section>
        <h2>7. Statistical Analysis Plan Summary</h2>
        <ul>
            <li><strong>Primary Analysis:</strong> Paired t‑test; confirm normality (Shapiro).</li>
            <li><strong>Secondary:</strong> LMM with fixed effects = visit; random intercept = participant.</li>
            <li><strong>Safety:</strong> AE counts by PT and severity.</li>
            <li><strong>Interim Data Cut (Week 20):</strong> Descriptive enrollment & adherence only.</li>
        </ul>
    </section>

    <section>
        <h2>8. TMF Structure</h2>
        <ul>
            <li><strong>Study-Level:</strong> Protocol, approvals, contracts, DMP, SAP, SMP, Monitoring reports, CAPA, IP docs.</li>
            <li><strong>Site-Level Binder:</strong> IRB letters, signed ICFs, Delegation log, IP logs, monitoring letters, close-out.</li>
        </ul>
    </section>

    <section>
        <h2>9. Patient Materials Package</h2>
        <ul>
            <li>8-page ICF (grade 8 readability).</li>
            <li>Wallet-size contact card.</li>
            <li>Survey FAQ sheet.</li>
        </ul>
    </section>

    <section>
        <h2>10. Document Inventory Matrix</h2>
        <table>
            <tr><th>Doc</th><th>Version</th><th>Storage</th><th>Appendix</th></tr>
            <tr><td>Protocol</td><td>v1.4</td><td>TMF 1.1</td><td>A</td></tr>
            <tr><td>ICF</td><td>v1.0</td><td>TMF 2.2</td><td>I</td></tr>
            <tr><td>Project Mgmt Plan</td><td>v1.0</td><td>TMF 1.3</td><td>B</td></tr>
            <tr><td>DMP</td><td>v1.0</td><td>TMF 5.1</td><td>C</td></tr>
            <tr><td>Edit‑Check CSV</td><td>v1.0</td><td>TMF 5.1</td><td>C</td></tr>
            <tr><td>SAP</td><td>v0.1</td><td>TMF 5.2</td><td>G</td></tr>
            <tr><td>Safety Mgmt Plan</td><td>v1.0</td><td>TMF 4.1</td><td>F</td></tr>
            <tr><td>Monitoring Plan</td><td>v1.0</td><td>TMF 6.1</td><td>D</td></tr>
            <tr><td>IP Plan</td><td>v1.0</td><td>TMF 8.1</td><td>E</td></tr>
            <tr><td>TMF Index</td><td>v1.0</td><td>TMF 0</td><td>H</td></tr>
            <tr><td>Patient Packet</td><td>v1.0</td><td>TMF 2.2</td><td>I</td></tr>
        </table>
    </section>

    <section>
        <h2>11. Governance & Roles</h2>
        <table>
            <tr><th>Role</th><th>Name</th><th>Start Date</th><th>Key KPIs</th></tr>
            <tr><td>Sponsor Exec</td><td>CEO</td><td>D‑0</td><td>Budget sign‑off, risk approval</td></tr>
            <tr><td>Medical Lead</td><td>TBD</td><td>D‑0 +7</td><td>SAE review ≤ 24 h</td></tr>
            <tr><td>CRO / PM</td><td>TENGU</td><td>Continuous</td><td>Milestone on‑time %, query closure 72 h</td></tr>
            <tr><td>CRA</td><td>TBD</td><td>SIV</td><td>Monitoring KPI adherence</td></tr>
            <tr><td>Data Manager</td><td>TBD</td><td>UAT start</td><td>Zero critical DB errors</td></tr>
            <tr><td>Statistician</td><td>TBD</td><td>Interim</td><td>SAP finalization by Week 30</td></tr>
        </table>
    </section>

    <section>
        <h2>12. Top Risks & Mitigations</h2>
        <ol>
            <li><strong>IRB Delay</strong> – Parallel sponsor budget approval; weekly chase.</li>
            <li><strong>Recruitment Lag</strong> – Diversity outreach ads; contingency site.</li>
            <li><strong>SAE Cluster</strong> – Trigger Safety CAPA & Medical Lead review.</li>
        </ol>
    </section>

    <section>
        <h2>13. Action Checklist</h2>
        <p class="checklist"><span>☐</span>Sponsor signs Master Blueprint</p>
        <p class="checklist"><span>☐</span>IRB package submitted</p>
        <p class="checklist"><span>☐</span>REDCap UAT passed</p>
        <p class="checklist"><span>☐</span>Codex dashboard live</p>
        <p class="checklist"><span>☐</span>SIV scheduled</p>
    </section>

    <footer style="text-align:center; padding:1rem 0; background:#eee;">
        Appendices: A Protocol v1.4 • B PM Plan & Gantt • C DMP & Edit‑Checks • D Monitoring Plan • E IP Plan • F Safety Mgmt Plan • G SAP Draft • H TMF Index • I Patient Materials
        <br>
        &copy; 2025 Tengu Muna. This prototype is for simulation purposes only. It is confidential and intended for demonstration during interviews. Do not share or reproduce without written permission.
    </footer>
</body>
</html>
